Magda Marquet

Insider Reports History

Location
San Diego, WA
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Magda Marquet:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcturus Therapeutics Holdings Inc. Director Common Stock 24,942 $798,892 $32.03 14 Jun 2024 Via Alma Life Sciences, LLC
ANAPTYSBIO, INC Director Common Stock 9,930 $485,070 $48.85 15 Jan 2026 Direct
Arcturus Therapeutics Holdings Inc. Director Common Stock 3,131 $100,286 $32.03 14 Jun 2024 Direct
ANAPTYSBIO, INC Director Restricted Stock Unit 4,000 $92,259 $15.30 06 Jan 2026 Direct
Immix Biopharma, Inc. Director Common Stock 46,092 $91,723 $1.99 20 Jun 2025 Direct
Immix Biopharma, Inc. Director Common Stock 20,000 $39,800 $1.99 20 Jun 2025 Via ALMA Life Sciences, LLC
Arcturus Therapeutics Holdings Inc. Director Deferred Stock Units 0 $0 $32.03 14 Jun 2024 Direct
Transcode Therapeutics, Inc. Director Stock Option (right to buy) 70,000 14 Jun 2024 Direct
Immix Biopharma, Inc. Director Stock Option (Right to Buy) 33,000 20 Jun 2025 Direct
Arcturus Therapeutics Holdings Inc. Director Stock option (right to buy) 15,000 09 Jun 2025 Direct
ANAPTYSBIO, INC Director Stock Option (right to buy) 0 15 Jan 2026 Direct

Insider Reports Filed by Magda Marquet

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANAB ANAPTYSBIO, INC 15 Jan 2026 4 -$243,321 4 Director 16 Jan 2026, 13:05
ANAB ANAPTYSBIO, INC 06 Jan 2026 2 $0 4 Director 08 Jan 2026, 16:05
IMMX Immix Biopharma, Inc. 20 Jun 2025 1 $0 4 Director 23 Jun 2025, 16:57
ANAB ANAPTYSBIO, INC 15 Jun 2025 2 $0 4 Director 17 Jun 2025, 18:32
ARCT Arcturus Therapeutics Holdings Inc. 09 Jun 2025 1 $0 4 Director 11 Jun 2025, 20:01
ANAB ANAPTYSBIO, INC 07 Jan 2025 2 $0 4 Director 07 Jan 2025, 17:30
ANAB ANAPTYSBIO, INC 15 Jun 2024 2 $0 4 Director 18 Jun 2024, 20:17
ARCT Arcturus Therapeutics Holdings Inc. 14 Jun 2024 3 $0 4 Director 18 Jun 2024, 21:00
RNAZ Transcode Therapeutics, Inc. 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:16
IMMX Immix Biopharma, Inc. 11 Jun 2024 1 $0 4 Director 21 Jun 2024, 17:45
IMMX Immix Biopharma, Inc. 15 May 2024 2 $0 4 Director 20 May 2024, 17:25
ANAB ANAPTYSBIO, INC 03 Jan 2024 2 $0 4 Director 05 Jan 2024, 16:59
IMMX Immix Biopharma, Inc. 06 Sep 2023 1 +$22,213 4 Director 08 Sep 2023, 17:46
IMMX Immix Biopharma, Inc. 05 Sep 2023 1 +$24,722 4 Director 06 Sep 2023, 16:33
IMMX Immix Biopharma, Inc. 31 Aug 2023 1 +$2,010 4 Director 05 Sep 2023, 18:43
IMMX Immix Biopharma, Inc. 11 Aug 2023 1 $0 4 Director 14 Aug 2023, 16:15
ARCT Arcturus Therapeutics Holdings Inc. 01 Aug 2023 2 $0 4 Director 03 Aug 2023, 16:09
RNAZ Transcode Therapeutics, Inc. 19 May 2023 1 $0 4 Director 19 May 2023, 20:08
RNAZ Transcode Therapeutics, Inc. 10 May 2023 1 $0 4 Director 10 May 2023, 18:12
ANAB ANAPTYSBIO, INC 06 Jan 2023 2 $0 4 Director 10 Jan 2023, 18:09
ARCT Arcturus Therapeutics Holdings Inc. 15 Dec 2022 1 +$39,996 4 Director 19 Dec 2022, 16:02
IMMX Immix Biopharma, Inc. 14 Jul 2022 1 $0 4 Director 18 Jul 2022, 06:10
ARCT Arcturus Therapeutics Holdings Inc. 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 19:16
RNAZ Transcode Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 22 Jun 2022, 20:25
ANAB ANAPTYSBIO, INC 10 Feb 2022 1 $0 4 Director 14 Feb 2022, 15:54
IMMX Immix Biopharma, Inc. 15 Dec 2021 0 $0 3 Director 15 Dec 2021, 20:02
RNAZ Transcode Therapeutics, Inc. 08 Jul 2021 0 $0 3 Director 08 Jul 2021, 21:52
ARCT Arcturus Therapeutics Holdings Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 18:32